agent < agents < ages

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000023 (2020)	Yehyun Park [Corée du Sud] ; Jae Hee Cheon [Corée du Sud]	Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.
000029 (2020)	Sara Benchérifa ; Bouchra Amine ; Imane El Binoune ; Samira Rostom ; Rachid Bahiri	Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy
000034 (2020)	Angelika Batta ; Bhupinder Singh Kalra ; Raj Khirasaria	Trends in FDA drug approvals over last 2 decades: An observational study
000037 (2020)	Huiqiong Zeng ; Baiwei Luo ; Yue Zhang ; Zhongyu Xie ; Zhizhong Ye	Treatment of reactive arthritis with biological agents: a review
000038 (2020)	Maria C. Cid [Espagne] ; Roberto Ríos-Garcés [Espagne] ; Nekane Terrades-García [Espagne] ; Georgina Espígol-Frigolé [Espagne]	Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies.
000048 (2020)	Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]	Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000051 (2020)	Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]	Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
000054 (2020)	Rongda Li [République populaire de Chine] ; Qi Wan [République populaire de Chine] ; Pan Chen [République populaire de Chine] ; Shufen Mao [République populaire de Chine] ; Qiuju Wang [République populaire de Chine] ; Xiaoxin Li [République populaire de Chine] ; Yi Yang [République populaire de Chine] ; Li Dong [République populaire de Chine]	Tocilizumab treatment in Felty's syndrome.
000077 (2020)	Lei Li [République populaire de Chine] ; Ranran Li [République populaire de Chine] ; Zhixiong Wu [République populaire de Chine] ; Xianghong Yang ; Mingyan Zhao [République populaire de Chine] ; Jiao Liu [République populaire de Chine] ; Dechang Chen [République populaire de Chine]	Therapeutic strategies for critically ill patients with COVID-19
000082 (2020)	Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud]	The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
000099 (2020)	Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]	The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000107 (2020)	Kyung Eun Kim ; Suwon Jeon ; Jisun Song ; Tae Sung Kim ; Min Kyung Jung ; Myun Soo Kim ; Sunyoung Park ; Seung Beom Park ; Jeong Min Park ; Hyun Jeong Park [Corée du Sud] ; Daeho Cho	The Novel Synthetic Peptide AESIS-1 Exerts a Preventive Effect on Collagen-Induced Arthritis Mouse Model via STAT3 Suppression
000109 (2020)	Eric Toussirot [France]	The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition
000110 (2020)	Anna Gluba-Brz Zka ; Beata Franczyk ; Robert Olszewski ; Jacek Rysz	The Influence of Inflammation on Anemia in CKD Patients
000134 (2020)	Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]	Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
000141 (2020)	Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada]	Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature.
000178 (2020)	Adelaide Sofia Batalha Figueiredo [Portugal] ; Ana Luísa Oliveira [Portugal] ; Ant Nio Caetano [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]	SAPHO: has the time come for tailored therapy?
000180 (2020)	Emily Yi-Chih Ting ; Albert C. Yang [États-Unis] ; Shih-Jen Tsai [Taïwan]	Role of Interleukin-6 in Depressive Disorder
000206 (2020)	Christos Koutsianas ; Konstantinos Thomas ; Dimitrios Vassilopoulos	Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000223 (2020)	Chih-Chia Lu [République populaire de Chine] ; Mei-Yu Chen [République populaire de Chine] ; Yuh-Lih Chang	Potential therapeutic agents against COVID-19: What we know so far
000231 (2020)	Katie Bechman [Royaume-Uni] ; Mark Yates [Royaume-Uni] ; Sam Norton [Royaume-Uni] ; Andrew P. Cope [Royaume-Uni] ; James B. Galloway [Royaume-Uni]	Placebo Response in Rheumatoid Arthritis Clinical Trials.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    agents
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021